Home » Thought Leadership » Podcasts » Speaking of Access: The Manage…

Speaking of Access: The Management of Gene Therapies (Now and in the Future)

May 13, 2020


Written by: Andrew Gould

Andrew Gould asks our US payer panel for their expert perspectives surrounding the management of gene therapies, both now and in the future.

Focusing on the launch of ZOLGENSMA – the panel discuss the potential considerations surrounding cost, management, push-back, and the lack of long-term data available.


Apple Podcasts